Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

Explore clinical trials studying Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss trial results

Completed

Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss

NCT02132130

Conditions: Ear Diseases, Hearing Disorders, Hearing Loss, +9 more
Locations: Novartis Investigative Site Kansas City, Kansas, United States

Novartis Investigative Site Baltimore, Maryland, United States

Novartis Investigative Site New York, United States

Novartis Investigative Site Portland, Oregon, United States

View Trial Details

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss trial results

Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss

Related conditions